Innovative Technology Targeted to Unmet Medical Needs
PEG Biosciences Inc (PBI), a biotechnology company located in New Jersey USA, specializes in the development of innovative therapeutics targeted to unmet medical needs based on its proprietary BioSynersys™ and ProbioTherapeutic™ technologies.
PBI focuses on novel drug delivery technology to create first-in-class and best-in-class drugs for the treatment of disease with particular emphasis in the fields of cancer, and infectious and autoimmune disease.
PBI’s business model is centered on the development of best-in-class new drugs and the reformulation of existing biological drugs based on its proprietary technology. The Company considers partnering and selling products to pharmaceutical and biotechnology companies for clinical studies and commercialization.
PBI’s advanced BioSynersys™ and ProbioTherapeutic™ drug delivery technology can be leveraged to help pharmaceutical and biotechnology partners develop and realize the full potential of their products. The PBI team is dedicated to working to create the next breakthrough medicine.